Depreciation and amortization expense

Name: Zevra Therapeutics, Inc. Depreciation and amortization expense by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Zevra Therapeutics, Inc.·Business Segments·1 segment·Rolls up to D&A

Breakdown

Segment	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	$1.65M	$392K	$362K	$368K
Total	$1.62M	$315K	$316K	$316K

Segments

Business SegmentsView metric